| Serial Number | 87229070 |
| Word Mark | VYRASA |
| Filing Date | Monday, November 7, 2016 |
| Status | 614 - ABANDONED PETITION TO REVIVE - DENIED |
| Status Date | Monday, November 5, 2018 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 14, 2017 |
| Goods and Services | Pharmaceutical preparations, namely, breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; none of the above relating to pharmaceutical products for the prevention or treatment of cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, November 10, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Allergan Sales, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Madison, NJ 07940 |
| Party Name | Allergan Sales, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Irvine, CA 92612 |
| Event Date | Event Description |
| Monday, November 5, 2018 | PETITION TO REVIVE-DENIED |
| Friday, September 7, 2018 | INCOMPLETE PETITION NOTICE MAILED |
| Friday, September 7, 2018 | ASSIGNED TO PETITION STAFF |
| Tuesday, September 4, 2018 | PETITION TO REVIVE-RECEIVED |
| Friday, September 7, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 6, 2018 | EXTENSION 1 GRANTED |
| Monday, March 5, 2018 | EXTENSION 1 FILED |
| Wednesday, September 5, 2018 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, September 4, 2018 | EXTENSION RECEIVED WITH TEAS PETITION |
| Tuesday, September 4, 2018 | PETITION TO REVIVE-GRANTED |
| Tuesday, September 4, 2018 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, April 9, 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Monday, April 9, 2018 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, September 5, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, July 23, 2017 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Friday, April 21, 2017 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| Monday, April 17, 2017 | ASSIGNED TO PETITION STAFF |
| Thursday, April 6, 2017 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Monday, March 27, 2017 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, March 14, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 14, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 22, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, February 3, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 3, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 3, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, February 3, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Friday, February 3, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 12, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 12, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 12, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 23, 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 23, 2016 | NON-FINAL ACTION E-MAILED |
| Friday, December 23, 2016 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 21, 2016 | ASSIGNED TO EXAMINER |
| Thursday, November 10, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, November 10, 2016 | NEW APPLICATION ENTERED IN TRAM |